Related Experiment Video
Updated: Dec 10, 2025

05:23
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
6.4K
RNA interference as a promising treatment against SARS-CoV-2
1Biosciences Department, Faculty of Science, COMSATS University Islamabad, Islamabad, Pakistan. ahmeddonia123@yahoo.com.
Summary
No vaccines or treatments exist for SARS-CoV-2. RNA interference (RNAi) was successful against SARS-CoV, suggesting RNAi could be a viable strategy against SARS-CoV-2.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- The emergence of SARS-CoV-2 necessitates novel therapeutic strategies.
- Current medical interventions for SARS-CoV-2 are limited.
- Previous research demonstrated the efficacy of RNA interference (RNAi) against the related SARS-CoV.
Purpose of the Study:
- To explore the potential of RNA interference (RNAi) as a therapeutic approach for SARS-CoV-2.
- To investigate the feasibility of targeting SARS-CoV-2 with RNAi based on prior successes with SARS-CoV.
Main Methods:
- Review of existing RNAi studies on SARS-CoV.
- Analysis of SARS-CoV-2 genome for potential RNAi targets.
- Hypothetical modeling of RNAi efficacy against SARS-CoV-2.
Main Results:
- Successful RNAi applications were documented for SARS-CoV.
- The genetic makeup of SARS-CoV-2 presents potential targets for RNAi.
- Extrapolation of successful SARS-CoV RNAi strategies to SARS-CoV-2 is theoretically plausible.
Conclusions:
- RNA interference (RNAi) presents a promising avenue for developing treatments against SARS-CoV-2.
- Further research into RNAi-based therapies for SARS-CoV-2 is warranted.
- Leveraging past RNAi successes offers a strategic approach to combatting the current pandemic.
More Related Videos
Related Concept Videos
siRNA - Small Interfering RNAs
18.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.0K
RNA Interference
27.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.5K
Experimental RNAi
7.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.0K
The Antiviral System of Bacteria and Archaea: CRISPR
491
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
491
Rous Sarcoma Virus (RSV) and Cancer
5.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.9K
Single Nucleotide Polymorphisms-SNPs
17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K

